Sofwave Medical reported a strong first quarter for fiscal 2026, with revenue rising 46% year-over-year to $24.4 million and net income turning positive at $1.3 million under IFRS. The company saw a 56% increase in recurring usage fees, reflecting growing adoption of its non-invasive aesthetic treatments, especially among patients using GLP-1 therapies. Gross margin remained robust at 75%, and operating expenses as a percentage of revenue decreased, signaling improved efficiency. With nearly 2,900 systems sold and over 865,000 treatments performed, Sofwave is capitalizing on rising demand for regenerative aesthetic solutions and plans to continue expanding its global market presence.
Cortea secured €12 million in funding led by Dawn Capital to develop AI-powered Audit Quality Agents that review audit reports and financial statements, identifying errors and inconsistencies before sign-off. These tools help audit firms improve qual...
Cortea secured €12 million in seed funding led by Dawn Capital to develop AI tools that enhance audit quality without compromising accuracy. Their Audit Quality Agents review audit reports and financial statements to detect inconsistencies and errors...
Hong Kong Tourism Board has launched the "Hong Kong Summer Fun" campaign featuring a series of vibrant summer events including the 50th Sun Life Hong Kong International Dragon Boat Festival, Pixar Summer Fest, and a major football event with top Euro...
Hong Kong Tourism Board has launched the "Hong Kong Summer Fun" campaign, featuring festivals, family attractions, sports events, and exclusive summer deals valid until August 31. Highlights include the 50th Sun Life Hong Kong International Dragon Bo...
XTransfer has been recognized for the second consecutive year in FXC Intelligence’s 2026 Top 100 Cross-Border Payments Companies list, highlighting its role in advancing global B2B payment solutions. The company, serving over 890,000 enterprises in 2...
